Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

311
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
311
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

262
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
262
Analgesia and Pain Management01:25

Analgesia and Pain Management

636
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
636
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

742
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
742
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

939
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
939
Pharmacovigilance01:19

Pharmacovigilance

860
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
860

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A retrospective, matched-tool comparison of the opioid risk tool (ORT) and revised opioid risk tool (ORT-R) in community pharmacy screenings.

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Commending Public Health in a Time of Uncertainty.

Journal of public health management and practice : JPHMP·2025
Same author

Dare 2 Discuss social media campaign: An educational initiative to improve opioid use disorder discussions between the pharmacist and patient.

Journal of the American Pharmacists Association : JAPhA·2025
Same author

The role of pharmacy in promoting public health: Pharmacy and public health in 2050.

Journal of the American Pharmacists Association : JAPhA·2024
Same author

A faculty development series on race and ethnicity in pharmacy education.

Currents in pharmacy teaching & learning·2024
Same author

Revisiting the opioid and naloxone education (ONE) program: Program evaluation using the RE-AIM model four years later.

Research in social & administrative pharmacy : RSAP·2024

Related Experiment Video

Updated: Jul 12, 2025

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.2K

A call to develop opioid risk assessment programs for implementation in the pharmacy setting.

Alyssa Hodges, Anna Skarphol, Mark A Strand

    Journal of the American Pharmacists Association : Japha
    |October 22, 2023
    PubMed
    Summary

    A validated opioid risk assessment tool is crucial for addressing the opioid epidemic. This tool can guide clinical decisions, improve patient safety, and reduce stigma associated with opioid use.

    More Related Videos

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
    07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    7.1K
    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
    10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    9.7K

    Related Experiment Videos

    Last Updated: Jul 12, 2025

    Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
    12:20

    Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

    Published on: June 10, 2013

    21.2K
    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
    07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    7.1K
    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
    10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    9.7K

    Area of Science:

    • Public Health
    • Clinical Medicine
    • Pharmacology

    Background:

    • The United States faces a significant opioid epidemic requiring evidence-based solutions.
    • Current approaches to opioid management need refinement to prioritize patient safety and appropriate prescribing.

    Purpose of the Study:

    • To advocate for the development and implementation of a validated opioid risk assessment tool.
    • To emphasize the importance of shifting focus from prescription volume to prescription appropriateness.
    • To highlight the need for non-opioid alternatives and accessible misuse resources for healthcare providers.

    Main Methods:

    • Review of current strategies in combating the opioid epidemic.
    • Analysis of the characteristics of an ideal opioid risk screening tool (transparency, specificity, validation).
    • Discussion on the role of healthcare providers in patient care and resource utilization.

    Main Results:

    • A cohesive, validated opioid risk assessment tool is proposed as a key solution.
    • The tool should guide clinical decision-making, avoiding the "weaponization" of risk scores.
    • Emphasis on appropriate prescribing, non-opioid therapies, and provider knowledge of local resources.

    Conclusions:

    • Implementing a standardized opioid risk assessment tool can enhance patient safety and care.
    • Reducing stigma and ensuring patient dignity are essential components of opioid use management.
    • A shift towards evidence-based, patient-centered strategies is necessary to effectively combat the opioid epidemic.